Upload

Loading...

This video is unavailable.

Sorry about that.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__
  1. 134

    Periodic fever syndromes

  2. 135

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  3. 136

    A lifelong challenge: periodic fever syndromes

  4. 137

    Connections

  5. 138

    Each Voice Counts - The Women: Part 1

  6. 139

    Each Voice Counts - The Women: Part 2

  7. 140

    Unanswered questions about living with advanced breast cancer

  8. 141

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  9. 142

    Novartis International Biotechnology Leadership Camp 2012

  10. 143

    Journey of Chronic Myeloid Leukemia (CML)

  11. 144

    A look at the past decade in GIST: Chapter 6

  12. 145

    A look at the past decade in GIST: Chapter 5

  13. 146

    A look at the past decade in GIST: Chapter 4

  14. 147

    Vision loss due to Retinal Vein Occlusion (RVO)

  15. 148

    Vision loss due to Diabetic Macular Edema (DME)

  16. 149

    Vision loss due to wet age-related macular degeneration (wet AMD)

  17. 150

    A look at the past decade in GIST: Chapter 3

  18. 151

    Building the next generation of scientists

  19. 152

    A look at the past decade in GIST: Chapter 2

  20. 153

    A look at the past decade in GIST: Chapter 1

  21. 154

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  22. 155

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  23. 156

    Advanced breast cancer 101

  24. 157

    The mTOR pathway in ER+ advanced breast cancer

  25. 158

    Life in a Circle

  26. 159

    Understanding advanced breast cancer

  27. 160

    A Gift for Living

  28. 161

    The Villages Miles Away

  29. 162

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  30. 163

    Could your dog or cat be suffering from an allergy?

  31. 164

    Innovating to help eliminate malaria

  32. 165

    Malaria milestone video message

  33. 166

    Leo and Kya, friends against malaria

  34. 167

    The need for progress: what if?

  35. 168

    The myelofibrosis educational journey

  36. 169

    Understanding the progression of myelofibrosis

  37. 170

    Understanding the management of myelofibrosis

  38. 171

    The myelofibrosis disease burden

  39. 172

    The disease pathway associated with myelofibrosis

  40. 173

    New research developments in myelofibrosis

  41. 174

    Delivery of child-friendly antimalarial hits the 100 million mark

  42. 175

    Treating India's Leprosy patients

  43. 176

    Treating leprosy, caring for patients

  44. 177

    "SMS for Life" is expanding

  45. 178

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  46. 179

    Critical issues facing the advanced breast cancer patient community

  47. 180

    Advice to newly diagnosed advanced breast cancer patients

  48. 181

    Insight into the advanced breast cancer patient journey

  49. 182

    Pioneering an innovative social business model to fight malaria

  50. 183

    New media: drivers of democratization and development?

  51. 184

    What is it like living with myelofibrosis (MF)?

  52. 185

    What is the prognosis of myelofibrosis (MF)?

  53. 186

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  54. 187

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  55. 188

    What is myelofibrosis (MF)?

  56. 189

    How is the patient journey for advanced breast cancer patients different?

  57. 190

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  58. 191

    What is progression free survival and why is it important?

  59. 192

    What guidance do you give patients and family coping with advanced breast cancer?

  60. 193

    What insights can you share with newly diagnosed patients?

  61. 194

    Molecular pathways:The future of research at NIBR

  62. 195

    The importance of organ donation

  63. 196

    Novartis BioCamp 2011 (German)

  64. 197

    Novartis BioCamp 2011 (French)

  65. 198

    How is research in advanced breast cancer evolving?

  66. 199

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  67. 200

    What can a patient expect if diagnosed with advanced breast cancer?

  68. 201

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  69. 202

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  70. 203

    How does the advanced breast cancer treatment journey differ for patients?

  71. 204

    Novartis Be Healthy

  72. 205

    Novartis BioCamp 2011

  73. 206

    A sign from above

  74. 207

    Charlie

  75. 208

    Happy endings

  76. 209

    Herpes #1

  77. 210

    Herpes it's black and white

  78. 211

    Herpes the Ninja virus

  79. 212

    Magical elves with HSV

  80. 213

    Open happiness

  81. 214

    Play it smart

  82. 215

    Quarantine

  83. 216

    Strings

  84. 217

    Ah! Real herpes

  85. 218

    Down there

  86. 219

    Don't let herpes put you off

  87. 220

    Arogya Parivar: A social business model to improve health in rural India

  88. 221

    Living with multiple myeloma

  89. 222

    What are the symptoms of myelofibrosis (MF)?

  90. 223

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  91. 224

    Animals & Research: Think how far we've come

  92. 225

    SMS for Life

  93. 226

    Alcon: helping the world see better

  94. 227

    Cataract Surgery

  95. 228

    Life with cataracts

  96. 229

    CEO Joseph Jimenez on Alcon merger

  97. 230

    Extraordinary dogs: enriching life for disabled veterans

  98. 231

    Improving access to healthcare: too big to solve alone

  99. 232

    Drug discovery and development process

to add this to Watch Later

Add to